Ngā hua rapu kaituhi :: APM

1

EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides mā Jörgen Carlsson, Kenneth Wester, Manuel de la Torre, Per‐Uno Malmström, Truls Gårdmark

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome mā Artur Mezheyeuski, Ulrika Segersten, Lina Leiss, Per‐Uno Malmström, Jiřı́ Hatina, Arne Östman, Carina Strell

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

<i>AdCD40L</i> Immunogene Therapy for Bladder Carcinoma—The First Phase I/IIa Trial mā Per‐Uno Malmström, Angelica Loskog, Camilla A. Lindqvist, Sara M. Mangsbo, Moa Fransson, Alkwin Wanders, Truls Gårdmark, Thomas H. Tötterman

I whakaputaina 2010

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer mā Karolina Boman, Anna Larsson, Ulrika Segersten, Eugenia Kuteeva, Henrik Johannesson, Björn Nodin, Jakob Eberhard, Mathias Uhlén, Per‐Uno Malmström, Karin Jirström

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer mā Mårten Lindén, Sara Bergström Lind, Corina Mayrhofer, Ulrika Segersten, Kenneth Wester, Yaroslav Lyutvinskiy, Roman A. Zubarev, Per‐Uno Malmström, Ulf Pettersson

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Basoluminal Carcinoma: A New Biologically and Prognostically Distinct Entity Between Basal and Luminal Breast Cancer mā Mervi Laakso, Minna Tanner, Jonas Nilsson, Tom Wiklund, Björn Erikstein, Pirkko Kellokumpu‐Lehtinen, Per‐Uno Malmström, Nils Wilking, Jonas Bergh, Jorma Isola

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer mā Tammer Hemdan, Mårten Lindén, Sara Bergström Lind, Arvind Venkat Namuduri, E. Sjöstedt, Teresita Díaz de Ståhl, Anna Asplund, Per‐Uno Malmström, Ulrika Segersten

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma mā Helena Nord, Ulrika Segersten, Johanna Sandgren, Kenneth Wester, Christer Busch, Uwe Menzel, Jan Komorowski, Jan P. Dumanski, Per‐Uno Malmström, Teresita Díaz de Ståhl

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe) mā Christel Häggström, Fredrik Liedberg, Oskar Hagberg, Firas Aljabery, Viveka Ströck, Abolfazl Hosseini, Truls Gårdmark, Amir Sherif, Per‐Uno Malmström, Hans Garmo, Staffan Jahnson, Lars Holmberg

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Multicenter Validation of Cyclin D1, MCM7, TRIM29, and UBE2C as Prognostic Protein Markers in Non-Muscle–Invasive Bladder Cancer mā Niels Fristrup, Karin Birkenkamp‐Demtröder, Thomas Reinert, Marta Sänchez‐Carbayo, Ulrika Segersten, Per‐Uno Malmström, Joan Palou, M. Álvarez-Múgica, Chin‐Chen Pan, Benedicte Parm Ulhøi, Michael Borre, Torben F. Ørntoft, Lars Dyrskjøt

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Cathepsin E, Maspin, Plk1, and Survivin Are Promising Prognostic Protein Markers for Progression in Non-Muscle Invasive Bladder Cancer mā Niels Fristrup, Benedicte Parm Ulhøi, Karin Birkenkamp‐Demtröder, Francisco Mansilla, Marta Sänchez‐Carbayo, Ulrika Segersten, Per‐Uno Malmström, Arndt Hartmann, Joan Palou, M. Álvarez-Múgica, Karsten Zieger, Michael Borre, Torben F. Ørntoft, Lars Dyrskjøt

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus mā Bernd J. Schmitz‐Dräger, Michael J. Droller, Vinata B. Lokeshwar, Yair Lotan, M’Liss A. Hudson, Bas W. van Rhijn, Michael Marberger, Yves Fradet, George P. Hemstreet, Per‐Uno Malmström, Osamu Ogawa, Pierre I. Karakiewicz, Shahrokh F. Shariat

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
13

Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours mā Moniek M. Vedder, Mirari Márquez, Esther W. de Bekker‐Grob, M. Luz Calle, Lars Dyrskjøt, Manoils Kogevinas, Ulrika Segersten, Per‐Uno Malmström, Ferrán Algaba, Willemien Beukers, Torben F. Ørntoft, Ellen C. Zwarthoff, Francisco X. Real, Núria Malats, Ewout W. Steyerberg

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy mā Kim E.M. van Kessel, Willemien Beukers, Irene Lurkin, Angelique Ziel‐van der Made, Kirstin A. van der Keur, Joost L. Boormans, Lars Dyrskjøt, Mirari Márquez, Torben F. Ørntoft, Francisco X. Real, Ulrika Segersten, Núria Malats, Per‐Uno Malmström, Wim Van Criekinge, Ellen C. Zwarthoff

I whakaputaina 2016

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Gene Expression Signatures Predict Outcome in Non–Muscle-Invasive Bladder Carcinoma: A Multicenter Validation Study mā Lars Dyrskjøt, Karsten Zieger, Francisco X. Real, Núria Malats, Alfredo Carrato, Carolyn D. Hurst, S.A. Kotwal, Margaret A. Knowles, Per‐Uno Malmström, Manuel de la Torre, Kenneth Wester, Yves Allory, Dimitri Vordos, Aurélie Caillault, François Radvanyi, Anne-Mette K. Hein, Jens Ledet Jensen, Klaus Møller‐Ernst Jensen, Niels Marcussen, Torben F. Ørntoft

I whakaputaina 2007

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non–muscle-invasive bladder cancer mā J. Alfred Witjes, Guido Dalbagni, R. Jeffrey Karnes, Shahrokh F. Shariat, Steven Joniau, Joan Palou, Vincenzo Serretta, S. Larré, Savino M. Di Stasi, Renzo Colombo, Marek Babjuk, Per‐Uno Malmström, Núria Malats, Jacques Irani, Jack Baniel, Tommaso Cai, K. Eugene, Peter Ardelt, John Varkarakis, Riccardo Bartoletti, Martin Spahn, Francesca Pisano, Paolo Gontero, Richard Sylvester

I whakaputaina 2016

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA — up... mā Yair Lotan, Trinity J. Bivalacqua, Tracy M. Downs, William C. Huang, Jeffrey A. Jones, Ashish M. Kamat, Badrinath R. Konety, Per‐Uno Malmström, James M. McKiernan, Michael A. O’Donnell, Sanjay Patel, Kamal S. Pohar, Matthew J. Resnick, Alexander Sankin, Angela Smith, Gary D. Steinberg, Edouard J. Trabulsi, Michael Woods, Siamak Daneshmand

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
18

The impact of re‐transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high‐grade/Grade 3 bladder cancer treated with bacille Calmette–Guér... mā Paolo Gontero, Richard Sylvester, Francesca Pisano, Steven Joniau, Marco Oderda, Vincenzo Serretta, S. Larré, Savino M. Di Stasi, Bas van Rhijn, Alfred Witjes, Anne J. Grotenhuis, Renzo Colombo, Alberto Briganti, Marek Babjuk, Viktor Soukup, Per‐Uno Malmström, Jacques Irani, Núria Malats, Jack Baniel, Roy Mano, Tommaso Cai, K. Eugene, Peter Ardelt, John Vakarakis, Riccardo Bartoletti, Guido Dalbagni, Shahrokh F. Shariat, Évanguelos Xylinas, R. Jeffrey Karnes, Joan Palou

I whakaputaina 2015

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk Groups mā Kim E.M. van Kessel, Kirstin A. van der Keur, Lars Dyrskjøt, Ferrán Algaba, Naeromy Y.C. Welvaart, Willemien Beukers, Ulrika Segersten, Bastian Keck, Tobias Maurer, Tatjana Simić, Marcus Horstmann, Marc‐Oliver Grimm, Gregers G. Hermann, Karin Mogensen, Arndt Hartmann, Niels Harving, Astrid Petersen, Jørgen Bjerggaard Jensen, Kerstin Junker, Joost L. Boormans, Francisco X. Real, Núria Malats, Per‐Uno Malmström, Torben F. Ørntoft, Ellen C. Zwarthoff

I whakaputaina 2018

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought mā Joan Palou, Francesca Pisano, Richard Sylvester, Steven Joniau, Vincenzo Serretta, S. Larré, Savino M. Di Stasi, Bas van Rhijn, Alfred Witjes, Anne J. Grotenhuis, Renzo Colombo, Alberto Briganti, M. Babjuk, Viktor Soukup, Per‐Uno Malmström, Jacques Irani, Núria Malats, Jack Baniel, Roy Mano, Tommaso Cai, K. Eugene, Peter Ardelt, John Varkarakis, Riccardo Bartoletti, Guido Dalbagni, Shahrokh F. Shariat, Évanguelos Xylinas, R. Jeffrey Karnes, Paolo Gontero

I whakaputaina 2018

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: